1,297
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Factors that Impact Susceptibility to Fiber-Induced Health Effects

, , , &
Pages 246-266 | Published online: 09 Jun 2011

REFERENCES

  • Abbatt , J. D. 1979 . History of the use and toxicity of thorotrast . Environ. Res. , 18 : 6 – 12 .
  • Addison , J. and McConnell , E. E. 2008 . A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles . Regul. Toxicol. Pharmacol. , 52 : S187 – S199 .
  • Altomare , D. A. , Menges , C. W. , Pei , J. , Zhang , L. , Skele-Stump , K. L. , Carbone , M. , Kane , A. B. and Testa , J. R. 2009 . Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice . Proc. Natl. Acad. Sci. USA , 106 : 3420 – 3425 .
  • Altomare , D. A. , Vaslet , C. A. , Skele , K. L. , De Rienzo , A. , Devarajan , K. , Jhanwar , S. C. , McClatchey , A. I. , Kane , A. B. and Testa , J. R. 2005 . A mouse model recapitulating molecular features of human mesothelioma . Cancer Res. , 65 : 8090 – 8095 .
  • Antman , K. H. , Pass , H. I. and Schiff , P. B. 2001 . “ Management of mesothelioma ” . In Cancer: Principles and practice of oncology , 6th , Edited by: DeVita , V. T. J. , Hellman , S. and Rosenberg , S. A. 1943 – 1969 . Philadelphia : Lippincott Williams & Wilkins .
  • Antman , K. , Shemin , R. , Ryan , L. , Klegar , K. , Osteen , R. , Herman , T , Lederman , G. and Corson , J. 1988 . Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965–1985 . J. Clin. Oncol. , 6 : 147 – 153 .
  • Ascoli , V. , Cavone , D. , Merler , E. , Barbieri , P. G. , Romeo , L. , Nardi , F. and Musti , M. 2007 . Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature . Am. J. Ind. Med. , 50 : 357 – 369 .
  • Ascoli , V. , Mecucci , C. and Knuutila , S. 2001 . Genetic susceptibility and familial malignant mesothelioma . Lancet , 357 : 1804
  • Ascoli , V. , Scalzo , C. C. , Bruno , C. , Facciolo , F. , Lopergolo , M. , Granone , P. and Nardi , F. 1998 . Familial pleural malignant mesothelioma: Clustering in three sisters and one cousin . Cancer Lett. , 130 : 203 – 207 .
  • Astoul , P. 2003 . Textbook of pleural diseases , Edited by: Light , R. W. and Lee , Y. C. G. New York : Arnold .
  • Baris , B. , Demir , A. U. , Shehu , V. , Karakoca , Y. , Kisacik , G. and Baris , Y. I. 1996 . Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma . J. Environ. Pathol. Toxicol. Oncol. , 15 : 183 – 189 .
  • Baris , I. , Simonato , L. , Artvinli , M. , Pooley , F. , Saracci , R. , Skidmore , J. and Wagner , C. 1987 . Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: A four-year study in the Cappadocian region of Turkey . Int. J. Cancer , 39 : 10 – 17 .
  • Baris , Y. I. 1991 . Fibrous zeolite (erionite)-related diseases in Turkey . Am. J. Ind. Med. , 19 : 374 – 378 .
  • Baris , Y. I. , Artvinli , M. and Sahin , A. A. 1979 . Environmental mesothelioma in Turkey . Ann. NY Acad. Sci. , 330 : 423 – 432 .
  • Baris , Y. I. and Grandjean , P. 2006 . Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite . JNCI , 98 : 414 – 417 .
  • Baris , Y. I. , Sahin , A. A. , Ozesmi , M. , Kerse , I. , Ozen , E. , Kolacan , B. , Altinors , M. and Goktepeli , A. 1978 . An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia . Thorax , 33 : 181 – 192 .
  • Baris , Y. I. , Saracci , R. , Simonato , L. , Skidmore , J. W. and Artvinli , M. 1981 . Malignant mesothelioma and radiological chest abnormalities in two villages in Central Turkey. An epidemiological and environmental investigation . Lancet , 1 : 984 – 987 .
  • Baser , M. E. , De Rienzo , A. , Altomare , D. , Balsara , B. R. , Hedrick , N. M. , Gutmann , D. H. , Pitts , L. H. , Jackler , R. K. and Testa , J. R. 2002 . Neurofibromatosis 2 and malignant mesothelioma . Neurology , 59 : 290 – 291 .
  • Baser , M. E. , Rai , H. , Wallace , A. J. and Evans , D. G. 2005 . Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation . Family Cancer , 4 : 321 – 322 .
  • Berman , D. W. and Crump , K. S. 2008 . A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type . Crit. Rev. Toxicol. , 38 ( suppl. 1 ) : 49 – 73 .
  • Bertino , P. , Marconi , A. , Palumbo , L. , Bruni , B. M. , Barbone , D. , Germano , S. , Dogan , A. U. , Tassi , G. F. , Porta , C. , Mutti , L. and Gaudino , G. 2007 . Erionite and asbestos differently cause transformation of human mesothelial cells . Int. J. Cancer , 121 : 12 – 20 .
  • Bianchi , A. B. , Mitsunaga , S. I. , Cheng , J. Q. , Klein , W. M. , Jhanwar , S. C. , Seizinger , B. , Kley , N. , Klein-Szanto , A. J. and Testa , J. R. 1995 . High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas . Proc. Natl. Acad. Sci. USA , 92 : 10854 – 10858 .
  • Bisconti , M. , Bisetti , A. and Bidoli , P. 2000 . Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: Only an apparent association? . Respiration , 67 : 223 – 228 .
  • Boutin , C. , Rey , F. , Gouvernet , J. , Viallat , J. R. , Astoul , P. and Ledoray , V. 1993 . Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging . Cancer , 72 : 394 – 404 .
  • BTS statement on malignant mesothelioma in the UK . 2007 . Thorax , 62 ( suppl. 2 ) : ii1 – ii19 .
  • Burdge , G. C. , Lillycrop , K. A. and Jackson , A. A. 2009 . Nutrition in early life, and risk of cancer and metabolic disease: Alternative endings in an epigenetic tale? . Br. J. Nutr. , 101 : 619 – 630 .
  • Calavrezos , A. , Koschel , G. , Husselmann , H. , Taylessani , A. , Heilmann , H. P. , Fabel , H. , Schmoll , H. J. , Dietrich , H. and Hain , E. 1988 . Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981–1985 . Klin. Wochenschr. , 66 : 607 – 613 .
  • Carbone , M. , Emri , S. , Dogan , A. U. , Steele , I. , Tuncer , M. , Pass , H. I. and Baris , Y. I. 2007 . A mesothelioma epidemic in Cappadocia: Scientific developments and unexpected social outcomes . Nat. Rev. Cancer , 7 : 147 – 154 .
  • Carbone , M. , Kratzke , R. A. and Testa , J. R. 2002 . The pathogenesis of mesothelioma . Semin. Oncol. , 29 : 217
  • Carbone , M. , Pannuti , A. , Zhang , L. , Testa , J. R. and Bocchetta , M. 2008 . A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells . Cancer Res. , 68 : 9488 – 9496 .
  • Ceresoli , G. L. , Locati , L. D. , Ferreri , A. J. , Cozzarini , C. , Passoni , P. , Melloni , G. , Zannini , P. , Bolognesi , A. and Villa , E. 2001 . Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma . Lung Cancer , 3 : 279 – 287 .
  • Chahinian , A. P. , Pajak , T. F. , Holland , J. F. , Norton , L. , Ambinder , R. M. and Mandel , E. M. 1982 . Diffuse malignant mesothelioma. Prospective evaluation of 69 patients . Ann. Intern. Med. , 96 : 746 – 755 .
  • Cheng , J. Q. , Jhanwar , S. C. , Klein , W. M. , Bell , D. W. , Lee , W. C. , Altomare , D. A. , Nobori , T. , Olopade , O. I. , Buckler , A. J. and Testa , J. R. 1994 . p16 Alterations and deletion mapping of 9p21-p22 in malignant mesothelioma . Cancer Res. , 5 : 5547 – 5551 .
  • Cheng , J. Q. , Lee , W. C. , Klein , M. A. , Cheng , G. Z. , Jhanwar , S. C. and Testa , J. R. 1999 . Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: Evidence for a two-hit mechanism of NF2 inactivation . Genes Chromosomes Cancer , 24 : 238 – 242 .
  • Chiosea , S. , Krasinskas , A. , Cagle , P. T. , Mitchell , K. A. , Zander , D. S. and Dacic , S. 2008 . Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas . Mod. Pathol. , 21 : 742 – 747 .
  • Cho , E. , Hunter , D. J. , Spiegelman , D. , Albanes , D. , Beeson , W. L. , van den Brandt , P. A. , Colditz , G. A. , Feskanich , D. , Folsom , A. R. , Fraser , G. E. , Freudenheim , J. L. , Giovannucci , E. , Goldbohm , R. A. , Graham , S. , Miller , A. B. , Rohan , T. E. , Sellers , T. A. , Virtamo , J. , Willett , W. C. and Smith-Warner , S. A. 2006 . Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: A pooled analysis of 8 prospective studies . Int. J. Cancer , 118 : 970 – 978 .
  • Cook , M. B. , Dawsey , S. M. , Freedman , N. D. , Inskip , P. D. , Wichner , S. M. , Quraishi , S. M. , Devesa , S. S. and McGlynn , K. A. 2009 . Sex disparities in cancer incidence by period and age . Cancer Epidemiol. Biomarkers Prev. , 18 : 1174 – 1182 .
  • Coplu , L. , Dumortier , P. , Demir , A. U. , Selcuk , Z. T. , Kalyoncu , F. , Kisacik , G. , DeVuyst , P. , Sahin , A. A. and Baris , Y. I. 1996 . An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos . J. Environ. Pathol. Toxicol. Oncol. , 15 : 177 – 182 .
  • Creaney , J. , Yeoman , D. , Naumoff , L. K. , Hof , M. , Segal , A. , Musk , A. W. , De Klerk , N. , Horick , N. , Skates , S. J. and Robinson , B. W. 2007 . Soluble mesothelin in effusions: A useful tool for the diagnosis of malignant mesothelioma . Thorax , 62 : 569 – 576 .
  • Cristaudo , A. , Foddis , R. , Bonotti , A. , Simonini , S. , Vivaldi , A. , Guglielmi , G. , Bruno , R. , Landi , D. , Gemignani , F. and Landi , S. 2010 . Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein . Occup. Environ. Med. , 67 : 233 – 236 .
  • Cristaudo , A. , Foddis , R. , Buselli , R. , Gattini , V. , Di Palma , N. and Guglielmi , G. 2006 . Medical surveillance of workers previously exposed to asbestos . Med. Lav. , 97 : 475 – 481 .
  • Cristaudo , A. , Foddis , R. , Vivaldi , A. , Guglielmi , G. , Dipalma , N. , Filiberti , R. , Neri , M. , Ceppi , M. , Paganuzzi , M. , Ivaldi , G. P. , Mencoboni , M. , Canessa , P. A. , Ambrosino , N. , Chella , A. , Mutti , L. and Puntoni , R. 2007 . Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer . Clin. Cancer Res. , 13 : 5076 – 5081 .
  • Curran , D. , Sahmoud , T. , Therasse , P. , van Meerbeeck , J. , Postmus , P. E. and Giaccone , G. 1998 . Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience . J. Clin. Oncol. , 16 : 145 – 152 .
  • Dacic , S. , Kothmaier , H. , Land , S. , Shuai , Y. , Halbwedl , I. , Morbini , P. , Murer , B. , Comin , C. , Galateau-Salle , F. , Demirag , F. , Zeren , H. , Attanoos , R. , Gibbs , A. , Cagle , P. and Popper , H. 2008 . Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas . Virchows Arch. , 453 : 627 – 635 .
  • Dawson , A. , Gibbs , A. , Browne , K. , Pooley , F. and Griffiths , M . 1992 . Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis . Cancer , 70 : 1183 – 1187 .
  • De Pangher Manzini , V. , Brollo , A. , Franceschi , S. , De Matthaeis , M. , Talamini , R. and Bianchi , C. 1993 . Prognostic factors of malignant mesothelioma of the pleura . Cancer , 72 : 410 – 417 .
  • Dianzani , I. , Gibello , L. , Biava , A. , Giordano , M. , Bertolotti , M. , Betti , M. , Ferrante , D. , Guarrera , S. , Betta , G. P. , Mirabelli , D. , Matullo , G. and Magnani , C. 2006 . Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study . Mutat. Res. , 599 : 124 – 134 .
  • Dogan , A. U. , Baris , Y. I. , Dogan , M. , Emri , S. , Steele , I. , Elmishad , A. G. and Carbone , M. 2006 . Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey . Cancer Res. , 66 : 5063 – 5068 .
  • Dumortier , P. , Coplu , L. , Broucke , I. , Emri , S. , Selcuk , T. , de Maertelaer , V. , De Vuyst , P. and Baris , I. 2001 . Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey . Occup. Environ. Med. , 58 : 261 – 266 .
  • Eckhardt , F. , Lewin , J. , Cortese , R. , Rakyan , V. K. , Attwood , J. , Burger , M. , Burton , J. , Cox , T. V. , Davies , R. , Down , T. A. , Haefliger , C. , Horton , R. , Howe , K. , Jackson , D. K. , Kunde , J. , Koenig , C. , Liddle , J. , Niblett , D. , Otto , T. , Pettett , R. , Seemann , S. , Thompson , C. , West , T. , Rogers , J. , Olek , A. , Berlin , K. and Beck , S. 2006 . DNA methylation profiling of human chromosomes 6, 20 and 22 . Nat Genet , 38 : 1378 – 1385 .
  • Emri , S. , Demir , A. , Dogan , M. , Akay , H. , Bozkurt , B. , Carbone , M. and Baris , I. 2002 . Lung diseases due to environmental exposures to erionite and asbestos in Turkey . Toxicol. Lett. , 127 : 251 – 257 .
  • Factor , R. E. , Dal Cin , P. , Fletcher , J. A. and Cibas , E. S. 2009 . Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma . Cancer Cytopathol. , 117 : 247 – 253 .
  • Flejter , W. L. , Li , F. P. , Antman , K. H. and Testa , J. R. 1989 . Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes . Genes Chromosomes Cancer , 1 : 148 – 154 .
  • Fleury-Feith , J. , Lecomte , C. , Renier , A. , Matrat , M. , Kheuang , L. , Abramowski , V. , Levy , F. , Janin , A. , Giovannini , M. and Jaurand , M. C. 2003 . Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours . Oncogene , 22 : 3799 – 3805 .
  • Flores-Staino , C. , Darai-Ramqvist , E. , Dobra , K. and Hjerpe , A. 2010 . Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions . Lung Cancer , 68 : 39 – 43 .
  • Fortes , C. , Forastiere , F. , Farchi , S. , Mallone , S. , Trequattrinni , T. , Anatra , F. , Schmid , G. and Perucci , C. A. 2003 . The protective effect of the Mediterranean diet on lung cancer . Nutr. Cancer , 46 : 30 – 37 .
  • Frizelle , S. P. , Grim , J. , Zhou , J. , Gupta , P. , Curiel , D. T. , Geradts , J. and Kratzke , R. A. 1998 . Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression . Oncogene , 16 : 3087 – 3095 .
  • Gallicchio , L. , Boyd , K. , Matanoski , G. , Tao , X. G. , Chen , L. , Lam , T. K. , Shiels , M. , Hammond , E. , Robinson , K. A. , Caulfield , L. E. , Herman , J. G. , Guallar , E. and Alberg , A. J. 2008 . Carotenoids and the risk of developing lung cancer: A systematic review . Am. J. Clin. Nutr. , 88 : 372 – 383 .
  • Gazdar , A. F. , Butel , J. S. and Carbone , M. 2002 . SV40 and human tumours: myth, association or causality? . Nat. Rev. Cancer , 2 : 957 – 964 .
  • Gemignani , F. , Neri , M. , Bottari , F. , Barale , R. , Canessa , P. A. , Canzian , F. , Ceppi , M. , Spitaleri , I. , Cipollini , M. , Ivaldi , G. P. , Mencoboni , M. , Scaruffi , P. , Tonini , G. P. , Ugolini , D. , Mutti , L. , Bonassi , S. and Landi , S. 2009 . Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism . Mutat. Res. , 671 : 76 – 83 .
  • Gibas , Z. , Li , F. P. , Antman , K. H. , Bernal , S. , Stahel , R. and Sandberg , A. A. 1986 . Chromosome changes in malignant mesothelioma . Cancer Genet. Cytogenet. , 20 : 191 – 201 .
  • Goodman , J. E. , Nascarella , M. A. and Valberg , P. A. 2009 . Ionizing radiation: A risk factor for mesothelioma . Cancer Causes Control , 20 : 1237 – 1254 .
  • Guey , L. T. , Garcia-Closas , M. , Murta-Nascimento , C. , Lloreta , J. , Palencia , L. , Kogevinas , M. , Rothman , N. , Vellalta , G. , Calle , M. L. , Marenne , G. , Tardon , A. , Carrato , A. , Garcia-Closas , R. , Serra , C. , Silverman , D. T. , Chanock , S. , Real , F. X. and Malats , N. 2010 . Genetic susceptibility to distinct bladder cancer subphenotypes . Eur. Urol. , 57 : 283 – 292 .
  • Guled , M. , Lahti , L. , Lindholm , P. M. , Salmenkivi , K. , Bagwan , I. , Nicholson , A. G. and Knuutila , S. 2009 . CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis . Genes Chromosomes Cancer , 48 : 615 – 623 .
  • Hagemeijer , A. , Versnel , M. A. , Van Drunen , E. , Moret , M. , Bouts , M. J. , van der Kwast , T. H. and Hoogsteden , H. C. 1990 . Cytogenetic analysis of malignant mesothelioma . Cancer Genet. Cytogenet. , 47 : 1 – 28 .
  • Hammar , S. P. , Bockus , D. , Remington , F. , Freidman , S. and LaZerte , G. 1989 . Familial mesothelioma: A report of two families . Hum. Pathol. , 20 : 107 – 112 .
  • Hando , J. C. , Nath , J. and Tucker , J. D. 1994 . Sex chromosomes, micronuclei and aging in women . Chromosoma , 103 : 186 – 192 .
  • Higginson , J. , Muir , C. S. and Muñoz , N. 1992 . “ Human cancer: Epidemiology and environmental causes ” . In Cambridge monographs on cancer research , New York : Cambridge University Press .
  • Hirvonen , A. , Pelin , K. , Tammilehto , L. , Karjalainen , A. , Mattson , K. and Linnainmaa , K. 1995 . Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma . Cancer Res. , 55 : 2981 – 2983 .
  • Hirvonen , A. , Saarikoski , S. T. , Linnainmaa , K. , Koskinen , K. , Husgafvel-Pursiainen , K. , Mattson , K. and Vainio , H. 1996 . Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders . JNCI , 88 : 1853 – 1856 .
  • Hodgson , J. T. and Darnton , A. 2000 . The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure . Ann. Occup. Hyg. , 44 : 565 – 601 .
  • Huncharek , M. 1995 . Genetic factors in the aetiology of malignant mesothelioma . Eur. J. Cancer , 31A : 1741 – 1747 .
  • Huncharek , M. 2002 . Non-asbestos related diffuse malignant mesothelioma . Tumori , 88 : 1 – 9 .
  • Huncharek , M. , Kelsey , K. , Muscat , J. and Christiani , D. 1996 . Parental cancer and genetic predisposition in malignant pleural mesothelioma: A case-control study . Cancer Lett. , 102 : 205 – 208 .
  • Illei , P. B. , Ladanyi , M. , Rusch , V. W. and Zakowski , M. F. 2003 . The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions . Cancer , 99 : 51 – 56 .
  • Ivanov , S. V. , Miller , J. , Lucito , R. , Tang , C. , Ivanova , A. V. , Pei , J. , Carbone , M. , Cruz , C. , Beck , A. , Webb , C. , Nonaka , D. , Testa , J. R. and Pass , H. I. 2009 . Genomic events associated with progression of pleural malignant mesothelioma . Int. J. Cancer , 124 : 589 – 599 .
  • Johnson , N. F. , Edwards , R. E. , Munday , D. E. , Rowe , N. and Wagner , J. C. 1984 . Pluripotential nature of mesotheliomata induced by inhalation of erionite in rats . Br. J. Exp. Pathol. , 65 : 377 – 388 .
  • Jongsma , J. , van Montfort , E. , Vooijs , M. , Zevenhoven , J. , Krimpenfort , P. , van der Valk , M. , van de Vijver , M. and Berns , A. 2008 . A conditional mouse model for malignant mesothelioma . Cancer Cell , 13 : 261 – 271 .
  • Kamb , A. , Gruis , N. A. , Weaver-Feldhaus , J. , Liu , Q. , Harshman , K. , Tavtigian , S. V. , Stockert , E. , Day , R. S. 3rd , Johnson , B. E. and Skolnick , M. H. 1994 . A cell cycle regulator potentially involved in genesis of many tumor types . Science , 264 : 436 – 440 .
  • Kaminsky , Z. , Wang , S. C. and Petronis , A. 2006 . Complex disease, gender and epigenetics . Ann. Med. , 38 : 530 – 544 .
  • Kim , J. Y. and Kwon , O. 2009 . Garlic intake and cancer risk: An analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims . Am. J. Clin. Nutr. , 89 : 257 – 264 .
  • Kliment , C. R. , Clemens , K. and Oury , T. D. 2009 . North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: A case report . Int. J. Clin. Exp. Pathol. , 2 : 407 – 410 .
  • Kruglyak , L. , Daly , M. J. , Reeve-Daly , M. P. and Lander , E. S. 1996 . Parametric and nonparametric linkage analysis: A unified multipoint approach . Am J Human Genet , 58 : 1347 – 1363 .
  • Ladanyi , M. 2005 . Implications of P16/CDKN2A deletion in pleural mesotheliomas . Lung Cancer , 49 : S95 – S98 .
  • Lam , T. K. , Gallicchio , L. , Lindsley , K. , Shiels , M. , Hammond , E. , Tao , X. G. , Chen , L. , Robinson , K. A. , Caulfield , L. E. , Herman , J. G. , Guallar , E. and Alberg , A. J. 2009 . Cruciferous vegetable consumption and lung cancer risk: A systematic review . Cancer Epidemiol. Biomarkers Prev. , 18 : 184 – 195 .
  • Landi , S. , Gemignani , F. , Neri , M. , Barale , R. , Bonassi , S. , Bottari , F. , Canessa , P. A. , Canzian , F. , Ceppi , M. , Filiberti , R. , Ivaldi , G. P. , Mencoboni , M. , Scaruffi , P. , Tonini , G. P. , Mutti , L. and Puntoni , R. 2007 . Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma . Int. J. Cancer , 120 : 2739 – 2743 .
  • Lanphear , B. P. and Buncher , C. R. 1992 . Latent period for malignant mesothelioma of occupational origin . J. Occup. Med. , 34 : 718 – 721 .
  • Li , F. P. , Dreyfus , M. G. and Antman , K. H. 1989 . Asbestos-contaminated nappies and familial mesothelioma . Lancet , 1 : 909 – 910 .
  • Li , F. P. , Lokich , J. , Lapey , J. , Neptune , W. B. and Wilkins , E. W. Jr. 1978 . Familial mesothelioma after intense asbestos exposure at home . J.Am. Med. Assoc. , 240 : 467
  • Li , G. , Passebosc-Faure , K. , Feng , G. , Lambert , C. , Cottier , M. , Gentil-Perret , A. , Fournel , P. , Perol , M. and Genin , C. 2007 . MN/CA9: A potential gene marker for detection of malignant cells in effusions . Biomarkers , 12 : 214 – 220 .
  • Lynch , H. T. , Katz , D. and Markvicka , S. E. 1985 . Familial mesothelioma: Review and family study . Cancer Genet. Cytogenet. , 15 : 25 – 35 .
  • Mahabir , S. , Spitz , M. R. , Barrera , S. L. , Beaver , S. H. , Etzel , C. and Forman , M. R. 2007 . Dietary zinc, copper and selenium, and risk of lung cancer . Int. J. Cancer , 120 : 1108 – 1115 .
  • Malik , M. A. , Upadhyay , R. , Modi , D. R. , Zargar , S. A. and Mittal , B. 2009 . Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley . Arch. Med. Res. , 40 : 416 – 423 .
  • Maltoni , C. , Minardi , F. and Morisi , L. 1982 . Pleural mesotheliomas in Sprague-Dawley rats by erionite: First experimental evidence . Environ. Res. , 29 : 238 – 244 .
  • Martensson , G. , Larsson , S. and Zettergren , L. 1984 . Malignant mesothelioma in two pairs of siblings: Is there a hereditary predisposing factor? . Eur. J. Respir. Dis. , 65 : 179 – 184 .
  • Milner , J. A. 2006 . Diet and cancer: facts and controversies . Nutr Cancer , 56 : 216 – 224 .
  • Montanaro , F. , Rosato , R. , Gangemi , M. , Roberti , S. , Ricceri , F. , Merler , E. , Gennaro , V. , Romanelli , A. , Chellini , E. , Pascucci , C. , Musti , M. , Nicita , C. , Barbieri , P. G. , Marinaccio , A. , Magnani , C. and Mirabelli , D. 2009 . Survival of pleural malignant mesothelioma in Italy: A population-based study . Int. J. Cancer , 124 : 201 – 207 .
  • Munoz , L. , Guzman , J. , Ponce de Leon , S. , Mutchinick , O. , Arista , J. and Vazquez , J. 1988 . Familial malignant pleural mesothelioma. Report of 3 cases . Rev. Invest. Clin. , 40 : 413 – 417 .
  • Murthy , S. S. and Testa , J. R. 1999 . Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma . J. Cell Physiol. , 180 : 150 – 157 .
  • Muscat , J. E. and Huncharek , M. 1996 . Dietary intake and the risk of malignant mesothelioma . Br. J. Cancer , 73 : 1122 – 1125 .
  • Musti , M. , Kettunen , E. , Dragonieri , S. , Lindholm , P. , Cavone , D. , Serio , G. and Knuutila , S. 2006 . Cytogenetic and molecular genetic changes in malignant mesothelioma . Cancer Genet. Cytogenet. , 170 : 9 – 15 .
  • Neragi-Miandoab , S. and Sugarbaker , D. J. 2009 . Chromosomal deletion in patients with malignant pleural mesothelioma . Interact. Cardiovasc. Thorac. Surg. , 9 : 42 – 44 .
  • Neri , M. , Filiberti , R. , Taioli , E. , Garte , S. , Paracchini , V. , Bolognesi , C. , Canessa , P. A. , Fontana , V. , Ivaldi , G. P. , Verna , A. , Bonassi , S. and Puntoni , R. 2005 . Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure . Mutat. Res. , 59 : 36 – 44 .
  • Neri , M. , Taioli , E. , Filiberti , R. , Paolo Ivaldi , G. , Aldo Canessa , P. , Verna , A. , Marroni , P. , Puntoni , R. , Hirvonen , A. and Garte , S. 2006 . Metabolic genotypes as modulators of asbestos-related pleural malignant mesothelioma risk: A comparison of Finnish and Italian populations . Int. J. Hyg Environ Health , 209 : 393 – 398 .
  • Neri , M. , Ugolini , D. , Dianzani , I. , Gemignani , F. , Landi , S. , Cesario , A. , Magnani , C. , Mutti , L. , Puntoni , R. and Bonassi , S. 2008 . Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases . Mutat. Res. , 659 : 126 – 136 .
  • Neumann , V. , Rutten , A. , Scharmach , M. , Muller , K. M. and Fischer , M. 2004 . Factors influencing long-term survival in mesothelioma patients—Results of the German mesothelioma register . Int. Arch. Occup. Environ. Health , 77 : 191 – 199 .
  • Nobori , T. , Miura , K. , Wu , D. J. , Lois , A. , Takabayashi , K. and Carson , D. A. 1994 . Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers . Nature , 368 : 753 – 756 .
  • Ohar , J. A. , Ampleford , E. J. , Howard , S. E. and Sterling , D. A. 2007 . Identification of a mesothelioma phenotype . Respir. Med. , 101 : 503 – 509 .
  • Omenn , G. S. , Goodman , G. E. , Thornquist , M. D. , Balmes , J. , Cullen , M. R. , Glass , A. , Keogh , J. P. , Meyskens , F. L. Jr. , Valanis , B. , Williams , J. H. Jr. , Barnhart , S. , Cherniack , M. G. , Brodkin , C. A. and Hammar , S. 1996 . Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial . JNCI , 88 : 1550 – 1559 .
  • Otte , K. E. , Sigsgaard , T. I. and Kjaerulff , J. 1990 . Massive exposure to asbestos and malignant mesothelioma, familial accumulation . Ugeskr Laeger , 152 : 3013 – 3014 .
  • Pass , H. I. , Lott , D. , Lonardo , F. , Harbut , M. , Liu , Z. , Tang , N. , Carbone , M. , Webb , C. and Wali , A. 2005 . Asbestos exposure, pleural mesothelioma, and serum osteopontin levels . N. Engl. J. Med. , 353 : 1564 – 1573 .
  • Pass , H. I. , Vogelzang , N. , Hahn , S. and Carbone , M. 2004 . Malignant pleural mesothelioma . Curr. Problem Cancer , 28 : 93 – 174 .
  • Pass , H. I. , Wali , A. , Tang , N. , Ivanova , A. , Ivanov , S. , Harbut , M. , Carbone , M. and Allard , J. 2008 . Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions . Ann. Thorac. Surg. , 85 : 265 – 272 . discussion 272
  • Popescu , N. C. , Chahinian , A. P. and DiPaolo , J. A. 1988 . Nonrandom chromosome alterations in human malignant mesothelioma . Cancer Res. , 48 : 142 – 147 .
  • Poulikakos , P. I. , Xiao , G. H. , Gallagher , R. , Jablonski , S. , Jhanwar , S. C. and Testa , J. R. 2006 . Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK . Oncogene , 25 : 5960 – 5968 .
  • Price , B. 1997 . Analysis of current trends in United States mesothelioma incidence . Am. J. Epidemiol. , 145 : 211 – 218 .
  • Pukkala , E. , Martinsen , J. I. , Lynge , E. , Gunnarsdottir , H. K. , Sparen , P. , Tryggvadottir , L. , Weiderpass , E. and Kjaerheim , K. 2009 . Occupation and cancer—Follow-up of 15 million people in five Nordic countries . Acta Oncol. , 48 : 646 – 790 .
  • Risberg , B. , Nickels , J. and Wagermark , J. 1980 . Familial clustering of malignant mesothelioma . Cancer , 45 : 2422 – 2427 .
  • Rivera , Z. , Strianese , O. , Bertino , P. , Yang , H. , Pass , H. and Carbone , M. 2008 . The relationship between simian virus 40 and mesothelioma . Curr. Opin. Pulm. Med. , 14 : 316 – 321 .
  • Robinson , B. W. , Creaney , J. , Lake , R. , Nowak , A. , Musk , A. W. , de Klerk , N. , Winzell , P. , Hellstrom , K. E. and Hellstrom , I. 2003 . Mesothelin-family proteins and diagnosis of mesothelioma . Lancet , 362 : 1612 – 1616 .
  • Roemer , H. C. , Weistenhofer , W. , Lohlein , D. , Geller , F. , Blomeke , B. and Golka , K. 2008 . N-Acetyltransferase 1 in colon and rectal cancer cases from an industrialized area . J. Toxicol. Environ Health A , 71 : 902 – 905 .
  • Rohl , A. N. , Langer , A. M. , Moncure , G. , Selikoff , I. J. and Fischbein , A. 1982 . Endemic pleural disease associated with exposure to mixed fibrous dust in Turkey . Science , 216 : 518 – 520 .
  • Roushdy-Hammady , I. , Siegel , J. , Emri , S. , Testa , J. R. and Carbone , M. 2001 . Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey . Lancet , 357 : 444 – 445 .
  • Ruffie , P. , Feld , R. , Minkin , S. , Cormier , Y. , Boutan-Laroze , A. , Ginsberg , R. , Ayoub , J. , Shepherd , F. A. , Evans , W. K. and Figueredo , A. 1989 . Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients . J. Clin. Oncol. , 7 : 1157 – 1168 .
  • Rusch , V. W. , Piantadosi , S. and Holmes , E. C. 1991 . The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial . J. Thorac. Cardiovasc. Surg. , 102 : 1 – 9 .
  • Rusch , V. W. and Venkatraman , E. S. 1999 . Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically . Ann. Thorac. Surg. , 68 : 1799 – 1804 .
  • Samson , M. K. , Wasser , L. P. , Borden , E. C. , Wanebo , H. J. , Creech , R. H. , Phillips , M. and Baker , L. H. 1987 . Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: A Sarcoma Intergroup Study . J. Clin. Oncol. , 5 : 86 – 91 .
  • Saracci , R. and Simonato , L. 2001 . Familial malignant mesothelioma . Lancet , 358 : 1813 – 1814 .
  • Sawan , C. , Vaissiere , T. , Murr , R. and Herceg , Z. 2008 . Epigenetic drivers and genetic passengers on the road to cancer . Mutat. Res. , 642 : 1 – 13 .
  • Scherpereel , A. and Lee , Y. G. 2007 . Biomarkers for mesothelioma . Curr. Opin. Pulm. Med. , 13 : 339 – 443 .
  • Schiffman , M. H. , Pickle , L. W. , Fontham , E. , Zahm , S. H. , Falk , R. , Mele , J. , Correa , P. and Fraumeni , J. F. Jr. 1988 . Case-control study of diet and mesothelioma in Louisiana . Cancer Res. , 48 : 2911 – 2915 .
  • Schmid , W. 1975 . The micronucleus test . Mutat. Res. , 31 : 9 – 15 .
  • Sebastien , P. , Gaudichet , A. , Bignon , J. and Baris , Y. I. 1981 . Zeolite bodies in human lungs from Turkey . Lab. Invest. , 44 : 420 – 425 .
  • Sekido , Y. , Pass , H. I. , Bader , S. , Mew , D. J. , Christman , M. F. , Gazdar , A. F. and Minna , J. D. 1995 . Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer . Cancer Res. , 55 : 1227 – 1231 .
  • Serio , G. , Gentile , M. , Pennella , A. , Marzullo , A. , Buonadonna , A. L. , Nazzaro , P. , Testini , M. , Musti , M. and Scattone , A. 2009 . Characterization of a complex chromosome aberration in two cases of peritoneal mesothelioma arising primarily in the hernial sac . Pathol. Int. , 59 : 415 – 421 .
  • Serrano , M. , Hannon , G. J. and Beach , D. 1993 . A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 . Nature , 366 : 704 – 707 .
  • Sobti , R. C. , Kaur , P. , Kaur , S. , Janmeja , A. K. , Jindal , S. K. , Kishan , J. and Raimondi , S. 2009 . Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population . DNA Cell Biol. , 28 : 443 – 449 .
  • Spirtas , R. , Connelly , R. R. and Tucker , M. A. 1988 . Survival patterns for malignant mesothelioma: The SEER experience . Int. J. Cancer , 41 : 525 – 530 .
  • Sugarbaker , D. J. , Flores , R. M. , Jaklitsch , M. T. , Richards , W. G. , Strauss , G. M. , Corson , J. M. , DeCamp , M. M. Jr. , Swanson , S. J. , Bueno , R. , Lukanich , J. M. , Baldini , E. H. and Mentzer , S. J. 1999 . Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients . J Thorac Cardiovasc Surg , 117 : 54 – 63 . discussion 63–65
  • Sullivan , P. A. 2007 . Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: Update of a cohort mortality study . Environ. Health Perspect. , 115 : 579 – 585 .
  • Surralles , J. , Hande , M. P. , Marcos , R. and Lansdorp , P. M. 1999 . Accelerated telomere shortening in the human inactive X chromosome . Am. J. Hum. Genet. , 65 : 1617 – 1622 .
  • Surralles , J. , Jeppesen , P. , Morrison , H. and Natarajan , A. T. 1996 . Analysis of loss of inactive X chromosomes in interphase cells . Am. J. Hum. Genet. , 59 : 1091 – 1096 .
  • Taguchi , T. , Jhanwar , S. C. , Siegfried , J. M. , Keller , S. M. and Testa , J. R. 1993 . Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma . Cancer Res. , 53 : 4349 – 4355 .
  • Tammilehto , L. 1992 . Malignant mesothelioma: Prognostic factors in a prospective study of 98 patients . Lung Cancer , 8 : 175 – 184 .
  • Taniguchi , T. , Karnan , S. , Fukui , T. , Yokoyama , Y. , Tagawa , H. , Yokoi , K. , Ueda , Y. , Mitsudomi , T. , Horio , Y. , Hida , T. , Yatabe , Y. , Seto , M. and Sekido , Y. 2007 . Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32 . Cancer Sci. , 9 : 438 – 446 .
  • Testa , J. R. and Jhanwar , S. C. 2003 . Textbook of pleural diseases , Edited by: Light , R. W. and Lee , Y. C. G. London, New York : Arnold .
  • Thurneysen , C. , Opitz , I. , Kurtz , S. , Weder , W. , Stahel , R. A. and Felley-Bosco , E. 2009 . Functional inactivation of NF2/merlin in human mesothelioma . Lung Cancer , 64 : 140 – 147 .
  • Tiainen , M. , Tammilehto , L. , Mattson , K. and Knuutila , S. 1988 . Nonrandom chromosomal abnormalities in malignant pleural mesothelioma . Cancer Genet. Cytogenet. , 33 : 251 – 274 .
  • Timblin , C. R. , Guthrie , G. D. , Janssen , Y. W. , Walsh , E. S. , Vacek , P. and Mossman , B. T. 1998 . Patterns of c-fos and c-jun proto-oncogene expression, apoptosis, and proliferation in rat pleural mesothelial cells exposed to erionite or asbestos fibers . Toxicol. Appl. Pharmacol. , 151 : 88 – 97 .
  • Ugolini , D. , Neri , M. , Ceppi , M. , Cesario , A. , Dianzani , I. , Filiberti , R. , Gemignani , F. , Landi , S. , Magnani , C. , Mutti , L. , Puntoni , R. and Bonassi , S. 2008 . Genetic susceptibility to malignant mesothelioma and exposure to asbestos: The influence of the familial factor . Mutat. Res. , 658 : 162 – 171 .
  • Vaissiere , T. , Sawan , C. and Herceg , Z. 2008 . Epigenetic interplay between histone modifications and DNA methylation in gene silencing . Mutat. Res. , 659 : 40 – 48 .
  • Van der Meeren , A. , Fleury , J. , Nebut , M. , Monchaux , G. , Janson , X. and Jaurand , M. C. 1992 . Mesothelioma in rats following intrapleural injection of chrysotile and phosphorylated chrysotile (chrysophosphate) . Int. J. Cancer , 50 : 937 – 942 .
  • Van Gelder , T. , Damhuis , R. A. and Hoogsteden , H. C. 1994 . Prognostic factors and survival in malignant pleural mesothelioma . Eur. Respir. J. , 7 : 1035 – 1038 .
  • Virta , R. L. 2006 . Zeolites , Edited by: U.S. Department of the Interior . Washington, DC : U.S. Geological Survey .
  • Virtamo , J. , Pietinen , P. , Huttunen , J. K. , Korhonen , P. , Malila , N. , Virtanen , M. J. , Albanes , D. , Taylor , P. R. and Albert , P. 2003 . Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up . J. Am. Med. Assoc. , 290 : 476 – 485 .
  • Wagner , J. C. , Skidmore , J. W. , Hill , R. J. and Griffiths , D. M. 1985 . Erionite exposure and mesotheliomas in rats . Br. J. Cancer , 51 : 727 – 730 .
  • Wagner , J. C. , Sleggs , C. A. and Marchand , P. 1960 . Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province . Br. J. Ind. Med. , 17 : 260 – 271 .
  • Wang , L. , Lee , I. M. , Zhang , S. M. , Blumberg , J. B. , Buring , J. E. and Sesso , H. D. 2009 . Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women . Am. J. Clin. Nutr. , 89 : 905 – 912 .
  • Weistenhoer , W. , Blaszkewicz , M. , Bolt , H. M. and Golka , K. 2008 . N-Acetyltransferase 2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany . J. Toxicol. Environ. Health A , 71 : 906 – 910 .
  • Whitehouse , A. C. , Black , C. B. , Heppe , M. S. , Ruckdeschel , J. and Levin , S. M. 2008 . Environmental exposure to Libby Asbestos and mesotheliomas . Am. J. Ind. Med. , 51 : 877 – 880 .
  • Woyengo , T. A. , Ramprasath , V. R. and Jones , P. J. 2009 . Anticancer effects of phytosterols . Eur. J. Clin. Nutr. , 63 : 813 – 820 .
  • Wynder , E. L. and Gori , G. B. 1977 . Contribution of the environment to cancer incidence: An epidemiologic exercise . J. Natl. Cancer Inst. , 58 : 825 – 832 .
  • Xiao , G. H. , Beeser , A. , Chernoff , J. and Testa , J. R. 2002 . p21-Activated kinase links Rac/Cdc42 signaling to merlin . J. Biol. Chem. , 277 : 883 – 886 .
  • Xiao , G. H. , Gallagher , R. , Shetler , J. , Skele , K. , Altomare , D. A. , Pestell , R. G. , Jhanwar , S. and Testa , J. R. 2005 . The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression . Mol. Cell. Biol. , 25 : 2384 – 2394 .
  • Yan , T. D. , Yoo , D. and Sugarbaker , P. H. 2006 . Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma . Eur. J. Surg. Oncol. , 32 : 948 – 953 .
  • Yang , C. T. , You , L. , Yeh , C. C. , Chang , J. W. , Zhang , F. , McCormick , F. and Jablons , D. M. 2000 . Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells . JNCI , 92 : 636 – 641 .